As critics of the pharmaceutical industry have begun floating the idea of banning direct-to-consumer (DTC) pharmaceutical advertising, the media has largely framed it as a crackdown on “Big Pharma.” But beneath the populist gloss lies a dangerous effort to normalize speech restrictions that should alarm anyone who values the First Amendment or fears such tactics […]